Literature DB >> 28557289

How do late terminations of pregnancy affect comparisons of stillbirth rates in Europe? Analyses of aggregated routine data from the Euro-Peristat Project.

B Blondel1, M Cuttini2, A D Hindori-Mohangoo3,4, M Gissler5, M Loghi6, C Prunet1, A Heino5, L Smith7, K van der Pal-de Bruin3, A Macfarlane8, J Zeitlin1.   

Abstract

OBJECTIVE: To describe how terminations of pregnancy at gestational ages at or above the limit for stillbirth registration are recorded in routine statistics and to assess their impact on comparability of stillbirth rates in Europe.
DESIGN: Analysis of aggregated data from the Euro-Peristat project.
SETTING: Twenty-nine European countries. POPULATION: Births and late terminations in 2010.
METHODS: Assessment of terminations as a proportion of stillbirths and derivation of stillbirth rates including and excluding terminations. MAIN OUTCOME MEASURES: Stillbirth rates overall and excluding terminations.
RESULTS: In 23 countries, it is possible to assess the contribution of terminations to stillbirth rates either because terminations are rare occurrences or because they can be distinguished from spontaneous stillbirths. Where terminations were reported, they accounted for less than 1.5% of stillbirths at 22+ weeks in Denmark, between 13 and 22% in Germany, Italy, Hungary, Finland and Switzerland, and 39% in France. Proportions were much lower at 24+ weeks, with the exception of Switzerland (7.4%) and France (39.2%).
CONCLUSIONS: Terminations represent a substantial proportion of stillbirths at 22+ weeks of gestation in some countries. Countries where terminations occur at 22+ weeks should publish rates with and without terminations in order to improve international comparisons and the policy relevance of stillbirth statistics. TWEETABLE ABSTRACT: For valid comparisons of stillbirth rates, data about late terminations of pregnancy are needed.
© 2017 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Euro-Peristat; international comparisons; pregnancy terminations; registration; stillbirth

Mesh:

Year:  2017        PMID: 28557289     DOI: 10.1111/1471-0528.14767

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  6 in total

1.  How can we make international comparisons of infant mortality in high income countries based on aggregate data more relevant to policy?

Authors:  Ania Zylbersztejn; Ruth Gilbert; Anders Hjern; Pia Hardelid
Journal:  BMC Pregnancy Childbirth       Date:  2017-12-19       Impact factor: 3.007

2.  Decreasing trend in preterm birth and perinatal mortality, do disparities also decline?

Authors:  Anita C J Ravelli; Martine Eskes; Joris A M van der Post; Ameen Abu-Hanna; Christianne J M de Groot
Journal:  BMC Public Health       Date:  2020-05-26       Impact factor: 3.295

3.  Clarity and consistency in stillbirth reporting in Europe: why is it so hard to get this right?

Authors:  Mika Gissler; Mélanie Durox; Lucy Smith; Béatrice Blondel; Lisa Broeders; Ashna Hindori-Mohangoo; Karen Kearns; Rumyana Kolarova; Marzia Loghi; Urelija Rodin; Katarzyna Szamotulska; Petr Velebil; Guy Weber; Oscar Zurriaga; Jennifer Zeitlin
Journal:  Eur J Public Health       Date:  2022-04-01       Impact factor: 3.367

4.  Producing valid statistics when legislation, culture and medical practices differ for births at or before the threshold of survival: report of a European workshop.

Authors:  L K Smith; B Blondel; J Zeitlin
Journal:  BJOG       Date:  2019-11-06       Impact factor: 6.531

5.  Paternity in male kidney transplant recipients: a French national survey, the PATeRNAL study.

Authors:  Annabel Boyer; Thierry Lobbedez; Mohamed Ouethrani; Angélique Thuillier Lecouf; Nicolas Bouvier; Valérie Châtelet; Bruno Hurault de Ligny
Journal:  BMC Nephrol       Date:  2020-11-16       Impact factor: 2.388

6.  Epidemiology of Antepartum Stillbirths in Austria-A Population-Based Study between 2008 and 2020.

Authors:  Dana Anaïs Muin; Hanns Helmer; Hermann Leitner; Sabrina Neururer
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.